Inhibition of Tumor Angiogenesis and Growth by a Small-Molecule Multi-FGF Receptor Blocker with Allosteric PropertiesFrançoise Bono, Michael Simons, Bart Jonckx et al.|Cancer Cell|2013Cited by 146
Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient MiceFrédérique Dol-Gleizes, Françoise Bono, Réjane Paumelle et al.|Arteriosclerosis Thrombosis and Vascular Biology|2008Cited by 124
P2Y4 nucleotide receptor: a novel actor in post-natal cardiac developmentMichael Horckmans, Didier Communi, Bernard Robaye et al.|Angiogenesis|2012Cited by 37
A New Synthetic FGF Receptor Antagonist Inhibits Arteriosclerosis in a Mouse Vein Graft Model and Atherosclerosis in Apolipoprotein E-Deficient MiceFrédérique Dol-Gleizes, Françoise Bono, Nathalie Delesque-Touchard et al.|PLoS ONE|2013Cited by 11
Effect of SR58611A, a potent beta-3 adrenoceptor agonist, on cutaneous wound healing in diabetic and obese micePaul Schaeffer, Jean‐Marc Herbert, A. Bernat et al.|European Journal of Pharmacology|2005Cited by 11